<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00457353</url>
  </required_header>
  <id_info>
    <org_study_id>ENTER_L_01486</org_study_id>
    <nct_id>NCT00457353</nct_id>
  </id_info>
  <brief_title>ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children</brief_title>
  <acronym>ENIGMA</acronym>
  <official_title>Phase III Comparative Study to Assess the Efficacy and Safety of Oral Rehydration Therapy (ORT) in Combination With Spores of Bacillus Clausii (Enterogermina)Versus ORT Alone, Administered for 5 Days With the Treatment of Acute Diarrhea in Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary:

        -  To demonstrate the efficacy of Enterogermina® in reducing the duration of acute diarrhea
           in children

      Secondary:

        -  To evaluate the safety of Enterogermina® in acute diarrhea in Indian children
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in duration of diarrhea</measure>
    <time_frame>Throughout the treatment period</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>Throughout the study period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean number of stools per day</measure>
    <time_frame>Throughout the treatment period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect on consistency of stools</measure>
    <time_frame>Throughtout the treatment period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting episodes per day</measure>
    <time_frame>Throughout the treatment period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Requirement of unscheduled intravenous transfusion</measure>
    <time_frame>Throughout the study period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for hospitalization</measure>
    <time_frame>Throughout the treatment period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">264</enrollment>
  <condition>Gastroenteritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of oral rehydration therapy with Bacillus clausii probiotic strain (1 vial twice daily, each vial containing 2 billion spores of Bacillus clausii)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of Oral rehydration therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bacillus Clausii</intervention_name>
    <description>For 5 days</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral rehydration therapy</intervention_name>
    <description>For 5 days</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non hospitalised infants and children attending clinic/outpatients with acute diarrhea
             (&gt;3 liquid or watery stools occurring in a 24-hour period) of less than 48 hours
             duration

        Exclusion Criteria:

          -  History of presence of blood, pus, or mucus in stools

          -  Severe dehydration (World Health Organization criteria)

          -  Severely malnourished patients

          -  Treatment with antibiotics, probiotics, or prebiotics within a period of 2 weeks
             before enrolment

          -  History of conditions known to producing immunodeficiency (Acquired Immune Deficiency
             Syndrome, other congenital immunodeficiency syndrome, drug therapy with steroids,
             anticancer drugs etc)

          -  Known hypersensitivity to Bacillus clausii or other probiotics.

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shah Pratik</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2007</study_first_submitted>
  <study_first_submitted_qc>April 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2007</study_first_posted>
  <last_update_submitted>January 20, 2009</last_update_submitted>
  <last_update_submitted_qc>January 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Medical Affairs Study Director</name_title>
    <organization>sanofi-aventis</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

